Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$35,000.00

Structural and Biochemical Characterization of Human Pleckstrin: a new target for treatment of inflammation in cardiovascular disease.

FY 2008-09

Summary
Cardiovascular disease represents the biggest health problem in Canada. This disease is complicated by the many factors that lead to its development. One of these factors is inflammation. One good way of fighting cardiovascular disease is to stop inflammation. Our objective is to stop inflammation in order to help prevent cardiovascular disease. Pleckstrin is an important protein in the steps leading to inflammation. If this protein is not controlled properly, there is an increase in inflammation. By learning more about how pleckstrin works we will be able to better understand how to control its function. Drugs are one way very effective way of controlling how proteins work. Drugs work by binding to proteins just like a hand fits into a glove. Therefore, in order to design drugs, we have to know what the protein looks like in 3D. If we know how pleckstrin works and what it looks like we can build a useful drug to treat inflammation. Our goal of regulating pleckstrin by developing drugs requires two pieces of information. First, we have to understand how pleckstrin works. All proteins work by interacting with other components in the cell. We will therefore study how pleckstrin interacts with its binding partners. Second, we need to know what pleckstrin looks like in 3D. This information is very important. It will help us understand how pleckstrin works and also how to design drugs. The drugs we are planning to design work by blocking the interaction of pleckstrin with other cellular components. Any drugs that show promising activity will be tested in cells. We will know that the drug is working when these cells no longer produce excessive amounts of inflammatory compounds associated with cardiovascular disease. Our work will improve the basic understanding of pleckstrin's role in inflammation. As well, it will lead to the development of new drugs that will aid in the treatment of inflammation.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
184646
Name
Jackson Sean G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Structural and Biochemical Characterization of Human Pleckstrin: a new target for treatment of inflammation in cardiovascular disease.
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$35,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Biochemistry; Cardiovascular Disease; Diabetes; Drug Design; Immunology; Inflammation; Ph Domains; Rage Signaling; Structure-Function; X-Ray Crystallography
Abstract
Cardiovascular disease represents the biggest health problem in Canada. This disease is complicated by the many factors that lead to its development. One of these factors is inflammation. One good way of fighting cardiovascular disease is to stop inflammation. Our objective is to stop inflammation in order to help prevent cardiovascular disease. Pleckstrin is an important protein in the steps leading to inflammation. If this protein is not controlled properly, there is an increase in inflammation. By learning more about how pleckstrin works we will be able to better understand how to control its function. Drugs are one way very effective way of controlling how proteins work. Drugs work by binding to proteins just like a hand fits into a glove. Therefore, in order to design drugs, we have to know what the protein looks like in 3D. If we know how pleckstrin works and what it looks like we can build a useful drug to treat inflammation. Our goal of regulating pleckstrin by developing drugs requires two pieces of information. First, we have to understand how pleckstrin works. All proteins work by interacting with other components in the cell. We will therefore study how pleckstrin interacts with its binding partners. Second, we need to know what pleckstrin looks like in 3D. This information is very important. It will help us understand how pleckstrin works and also how to design drugs. The drugs we are planning to design work by blocking the interaction of pleckstrin with other cellular components. Any drugs that show promising activity will be tested in cells. We will know that the drug is working when these cells no longer produce excessive amounts of inflammatory compounds associated with cardiovascular disease. Our work will improve the basic understanding of pleckstrin's role in inflammation. As well, it will lead to the development of new drugs that will aid in the treatment of inflammation.
Competitiondate
200810
Approvedterm2
1 yr 0 mth
Pinamesdelim
Jackson, Sean G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $35,000~ $0~